// App-Quantinova.ai

e11569 : Utilization of adjuvant trastuzumab for T1a,b N0 HER2+ breast cancer in Ontario.

Researchers

Presenter

  • Andrea Eisen

Principal Investigators

  • Lyndee Yeung

  • Scott Gavura

  • Zachary M Brown

  • Maureen E. Trudeau

Medical Centers

  • Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada

  • Cancer Care Ontario, Toronto, ON, CanadaOdette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Neutropenia

  • Solid malignancies

Biomarkers

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • Trastuzumab

Outcome

  • Positive

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved